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Sources of stem cells for bone regeneration
A stem cell is a cell from the embryo, foetus or adult that is capable of asymmetric cellular divisions to parent and daughter cells and thus has the capacity of self-renewal and multipotent differentiation into specialized cells of the body. The most widely used sources of bone stem cells along with their advantages and drawbacks can be found in
. [4] or perhaps via somatic cell nuclear transfer. Recently, human-induced pluripotent stem cells were generated by the ectopic expression of ESC-specific transcription factors in somatic cells [5, 6] .
Embryonic stem cells (ESC) derive from the inner cells of the blastocyst and are characterized by high telomerase expression, normal and stable karyotype and the ability to form cells belonging to any of the three germ layers [1-3]. The ethical issue that impedes the application of hESC could be resolved through pluripotent (hESC-like) cells that do not require fertilization for their generation, but can be isolated from embryos developed directly from oocytes via parthenogenesis
Mesenchymal [7] , periosteum [8] and synovium [9] . Late plastic adherent MSC have recently shown to differentiate into osteoblasts [10] .
Stem cells capable of multilineage differentiation similar to MSC were demonstrated in adipose tissue (ADSC) [11] . ADSC differentiated into functional osteoblasts when cultured on titanium [12] , hydroxyapatite, cancellous human bone fragments or deproteinized bovine bone granules [13, 14] .
In addition to the endothelial progenitor cells, circulating osteoblast-lineage cells were also isolated from human peripheral blood [15] and these cells formed ectopic bone when implanted in tissues in vivo [16] .
MSC with osteogenic potential are present in the umbilical blood [17] , umbilical cord perivascular cells [18] and Wharton's jelly [19] .
A variety of different stem cell populations were described in human amniotic fluid (AFSC) [20] , which, in turn, formed embryoid bodies [21] , showed high proliferative capacity and differentiate along the adipogenic, osteogenic, myogenic, endothelial, neurogenic and hepatic pathways [22] . Human AFSC seeded onto scaffolds and cultured in osteogenic medium supported the formation of highly mineralized tissue upon implantation in immunodeficient mice, without teratoma formation [23] .
Human foetal bone cells may be an alternative to MSC. Foetal osteoblasts have a doubling time comparable to MSC but start calcium deposition earlier [24, 25] . When seeded on porous scaffolds, they promoted bone repair in rats with critical size defects [26] .
Stem cells, similar to bone marrow-derived MSC, were demonstrated in dental pulp [27] . Five different types of human dental [37] .
Markers for the identification of adult bone stem cells
Effective methods of cell sorting and cell enrichment are useful for isolating homogeneous cell preparations [38, 39] [45] .
Surface marker expressions may be influenced by species differences [46] , tissue source [47, 48] [63] . [67] .
Micro-R29b has been found to be up-regulated during the differentiation of MC3T3 mouse pre-osteoblastic cells; its expression inhibits a number of negative regulators of osteoblast differentiation which affect Smad, ERK, p38 MAPK and Wnt signalling pathways. Furthermore, miR-29b directly targets several collagen genes (COL1A1, COL5A3 and COL4A2), preventing fibrosis and facilitating extracellular matrix mineralization at late stages of differentiation [64]. Micro-R-29a and -29c interact with osteonectin mRNA and their increased expression during osteoblast differentiation in vitro correlates with the reduction of osteonectin protein during the mineralization process [65]. By employing a library of miRNA inhibitors, Schoolmeesters et al. identified miR-148b, miR-26a and miR-489 as key regulators of MSC osteogenic differentiation [66]. In a recent study, in vitro and in vivo evidence ascribed a critical role to miR-2861 in osteoblast differentiation. miR-2861 is able to induce osteoblast differentiation by targeting histone deacetylase 5 (HDAC5), which deacetylates Runx2, therefore enhancing its degradation. Moreover, the authors found that a homozygous mutation in the miR-2861 precursor which blocks the expression of the mature microRNA, contributed to the development of primary osteoporosis in two related adolescents
Signaling pathways of osteoblast differentiation
␤-Catenin, a central component of the cadherin cell adhesion complex, has an essential role in the Wingless/Wnt signaling pathway for osteoblast differentiation [68]. Wnt pathway is initiated through the binding of a Wnt ligand to the seven-transmembrane domain-spanning Frizzled receptor and the low-density lipoprotein receptor-related protein 5 and 6 (LRP5/6) co-receptors. As a consequence, cytosolic ␤-catenin escapes phosphorylation by glycogen synthase kinase (GSK)-3 ␤, which phosphorylation would be followed by degradation in the ubiquitin/proteasome pathway. As a result of Wnt pathway activation the now stabilized ␤-catenin translocates to the nucleus, binds to T cell factor/lymphoid enhancer binding factor (TCF/LEF) transcription factors, and regulates downstream gene expression. In human beings, the mutations in the Wnt co-receptor LRP5 lead to decreased or increased canonical Wnt signaling, which result in osteoporosis or a high bone mass phenotype, respectively. LRP5 mutations and the level of Wnt signalling were shown to determine the differentiation of hMSC into osteoblasts or adipocytes.
Particularly, activating mutation T253I of LRP5 enhanced osteogenesis and inhibited adipogenesis, whereas inactivating mutation T244M of LRP5 exerted opposite effects [69] .
Control of bone remodelling by the nervous system
Bone remodelling is also under the influence of central and peripheral neural control [70] [72] . [76] .
In vivo models
Orthopaedic applications of bone stem cell technology
The orthopaedic application of bone stem cells may be of use when bone repair is impeded because of acquired or congenital [77] 
